Is Abbvie A Buy at Buying

Is Abbvie A Buy. According to analysts' consensus price target of $136.77, abbvie has a forecasted upside of 1.4% from its current price of $134.88. Mizuho analyst vamil divan maintains abbvie (nyse:abbv) with a buy and raises the price target from $132 to $154.

Abbv is one such name. Breaking things down more, abbvie is a member of the large cap pharmaceuticals industry, which includes 14 individual companies and currently sits at. The company's fundamentals are solid, and its market strategy makes it a strong competitor in the dietary supplement and drug industry.

How Safe Is AbbVie, Inc.'s Dividend Now? The Motley Fool

There's no way abbvie will face a drop in its market price. Big money buying up abbvie. Here are some reasons to invest in the stock now. Abbvie has a zacks rank #2 (buy.